Stockholders’ Equity (Details) - Schedule of restricted stock unit activity - Restricted Stock Units (RSUs) [Member] - $ / shares |
12 Months Ended | |
---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Stockholders’ Equity (Details) - Schedule of restricted stock unit activity [Line Items] | ||
Shares, Unvested balance, beginning | 1,431,922 | 625,000 |
Weighted Average Grant Date Fair Value, Unvested balance, beginning | $ 12.12 | $ 2.8 |
Weighted Average Vesting Period (Years), beginning | 2 years 6 months | 1 year 3 months |
Shares, Granted | 190,860 | 1,458,172 |
Weighted Average Grant Date Fair Value, Granted | $ 2.52 | $ 7.98 |
Shares, Vested | (512,755) | (526,250) |
Weighted Average Grant Date Fair Value, Vested | $ 8.06 | $ 3.75 |
Cancelled | (125,000) | |
Cancelled | $ 2.8 | |
Shares, Unvested balance, ending | 1,110,027 | 1,431,922 |
Weighted Average Grant Date Fair Value, Unvested balance, ending | $ 6.89 | $ 12.12 |
Weighted Average Vesting Period (Years), ending | 1 year 6 months 7 days | 2 years 6 months |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted Average Vesting Period. No definition available.
|
X | ||||||||||
- Definition For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Number of options vested. No definition available.
|
X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|
X | ||||||||||
- Details
|